Why do we need noncommercial, investigator-initiated clinical trials?

被引：13
|
作者：
Tyndall, Alan [1 ]
机构：
[1] Univ Basel Hosp, Felix Platter Spital, Dept Rheumatol, CH-4012 Basel, Switzerland
来源：
NATURE CLINICAL PRACTICE RHEUMATOLOGY | 2008年 / 4卷 / 07期
关键词：
D O I：
10.1038/ncprheum0814
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：354 / 355
页数：2
相关论文
共 50 条
  • [41] EVOLUTION OF INVESTIGATOR-INITIATED CLINICAL STUDIES IN A HEALTH RESEARCH INSTITUTE
    Llanos, L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 50 - 50
  • [42] Trends in Investigator-Initiated Clinical Studies at a University Hospital after Enforcement of the 2018 Clinical Trials Act in Japan
    Sato, Yasutaka
    Sakaguchi, Satoshi
    Takechi, Kenshi
    Chuma, Masayuki
    Yagi, Kenta
    Kane, Chikako
    Goda, Mitsuhiro
    Hamano, Hirofumi
    Aoe, Yuki
    Nokihara, Hiroshi
    Kubo, Yoshiaki
    Hashimoto, Ichiro
    Yanagawa, Hiroaki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (03) : 374 - 377
  • [43] A program to provide regulatory support for investigator-initiated clinical research
    Arbit, HM
    Paller, MS
    ACADEMIC MEDICINE, 2006, 81 (02) : 146 - 153
  • [44] "It Takes a Village" - investigator-initiated clinical trials in melanoma and non-melanoma skin cancers (NMSCs)
    Paton, Elizabeth
    Diamante, Katrina
    Economides, Alex
    Williams, Narelle
    Shackleton, Mark
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 201 - 202
  • [45] Clinical trials referral resource - Investigator-initiated health-related quality-of-life research
    Rowland, JH
    Varricchio, CG
    Trimble, EL
    Gore-Langton, RE
    ONCOLOGY-NEW YORK, 2001, 15 (10): : 1284 - +
  • [46] Do we need more clinical trials?
    van Noesel, Max M.
    PEDIATRIC BLOOD & CANCER, 2023, 70 (05)
  • [47] INFRASTRUCTURAL CAPABILITY OF INVESTIGATOR-INITIATED TRIALS INVOLVING UNAPPROVED INVESTIGATIONAL DRUGS IN JAPAN
    Shimizu, T.
    Kaneda, H.
    Tsurutani, J.
    Okamoto, K.
    Tanaka, K.
    Ohnishi, R.
    Nomura, M.
    Aida, H.
    Hashii, C.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2013, 24
  • [48] Lessons learnt from 15 years of investigator-initiated trials on axial spondyloarthritis
    Sieper, J.
    Braun, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2015, 74 (02): : 125 - 131
  • [49] Academic investigator-initiated trials and the challenge of sponsor responsibility: the Cologne Sponsor Model
    Georgias, Christine
    Grunow, Andrea
    Olderog, Miriam
    May, Alexander
    Paulus, Ursula
    CLINICAL TRIALS, 2012, 9 (06) : 781 - 787
  • [50] Protocol performance metrics and resource utilization of phase II investigator-initiated trials
    Durivage, H.
    Bridges, K. D.
    Sauers, J.
    Wellons, M.
    Baker, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345